Evidence map›Paper›PMID 38045286›Full record

ArticlebioRxiv : the preprint server for biology2023

Engineering luminopsins with improved coupling efficiencies.

Ashley Slaviero, Nipun Gorantla, Jacob Simkins, Emmanuel L Crespo, Ebenezer C Ikefuama, Maya O Tree, Mansi Prakash, Andreas Björefeldt, Lauren M Barnett, Gerard G Lambert and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ashley SlavieroCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Nipun GorantlaCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Jacob SimkinsCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Emmanuel L CrespoCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Ebenezer C IkefuamaCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Maya O TreeCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Mansi PrakashCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Andreas BjörefeldtCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Lauren M BarnettUniversity of California San Diego, Department of Neurosciences, La Jolla, California, United States.
Gerard G LambertUniversity of California San Diego, Department of Neurosciences, La Jolla, California, United States.
Diane LipscombeBrown University, Carney Institute for Brain Science, Providence, Rhode Island, United States.ORCID 0000-0002-7146-9119
Christopher I MooreBrown University, Carney Institute for Brain Science, Providence, Rhode Island, United States.
Nathan C ShanerUniversity of California San Diego, Department of Neurosciences, La Jolla, California, United States.
Ute HochgeschwenderCentral Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.ORCID 0000-0001-5165-6518
Central Michigan University · USUniversity of California San Diego · USAllen Institute for Brain Science · US

Funding

BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for NeuromodulationU01NS099709 · NINDS · CENTRAL MICHIGAN UNIVERSITY · PI HOCHGESCHWENDER, UTE H, MOORE, CHRISTOPHER I · 2016 to 2018
$2.4M
Probes for Luminescence-based Superresolution MicroscopyR01GM121944 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHANER, NATHAN CHRISTOPHER · 2017 to 2020
$1.3M
Genetically Encoded Light-Production and Light-Sensing for Neuronal ManipulationR21MH101525 · NIMH · DUKE UNIVERSITY · PI HOCHGESCHWENDER, UTE H · 2013 to 2015
$434k
NIGMS NIH HHS R01 GM121944NIMH NIH HHS R21 MH101525NINDS NIH HHS U01 NS099709
6 · The paper itself

Abstract

Significance: Luminopsins (LMOs) are bioluminescent-optogenetic tools with a luciferase fused to an opsin that allow bimodal control of neurons by providing both optogenetic and chemogenetic access. Determining which design features contribute to the efficacy of LMOs will be beneficial for further improving LMOs for use in research. Aim: We investigated the relative impact of luciferase brightness, opsin sensitivity, pairing of emission and absorption wavelength, and arrangement of moieties on the function of LMOs. Approach: We quantified efficacy of LMOs through whole cell patch clamp recordings in HEK293 cells by determining coupling efficiency, the percentage of maximum LED induced photocurrent achieved with bioluminescent activation of an opsin. We confirmed key results by multielectrode array (MEAs) recordings in primary neurons. Results: Luciferase brightness and opsin sensitivity had the most impact on the efficacy of LMOs, and N-terminal fusions of luciferases to opsins performed better than C-terminal and multi-terminal fusions. Precise paring of luciferase emission and opsin absorption spectra appeared to be less critical. Conclusions: Whole cell patch clamp recordings allowed us to quantify the impact of different characteristics of LMOs on their function. Our results suggest that coupling brighter bioluminescent sources to more sensitive opsins will improve LMO function. As bioluminescent activation of opsins is most likely based on Förster resonance energy transfer (FRET), the most effective strategy for improving LMOs further will be molecular evolution of luciferase-fluorescent protein-opsin fusions.

Indexed as

bioluminescenceFörster resonance energy transferluciferaseopsinoptogeneticswhole cell patch clamp recording

Identifiers

PMID38045286
PMCPMC10690276
OpenAlexW4388923392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.